According to the World Health Organization, Abbott has launched the world’s first medical device that can be implanted in the youngest infants (weighing only 700 grams) using a minimally invasive patent procedure or PDA.
Responding to an e-mail inquiry, the company said the launch was pan-Armenian, with a focus on centers with a Neonatal Intensive Care Unit (NICU) staffed by skilled pediatric cardiologists.
The condition is generally known as a “heart hole”.
The Amplatzer Piccolo Occluder, a device smaller than a pea, gives hope to premature infants – babies who need corrective care – they may not respond to medicine and run the risk of corrective surgery, says Abbott.
The occluder is a self-dissolving, wire mesh device that is inserted through a small incision in the leg միջոցով accompanied by vessels into the heart, where it is inserted to close the opening in the heart. It is designed so that the doctor can insert it through the aorta or pulmonary artery, as well as restore it, redistribute the device for optimal placement and release.
Because the device is installed with a minimally invasive procedure, many extremely premature infants in the intensive care unit of a neonatal intensive care unit can be weaned immediately after the assisted ventilation procedure.
The press release quoted Payal Agrawal, general manager of Abbott’s Structural Heart business in the Indian subcontinent, as saying that Piccolo was a possible advance in the most vulnerable care standards for premature infants who could not be operated on. to restore their hearts.
“This product is a potentially life-saving breakthrough that will help us heal these delicate newborns who would not otherwise be able to survive,” said Edwin Francis, Senior Advisor, Ernacum, Head of Pediatric Cardiology at Liz Hospital, who recently posted this. device in a premature baby weighing 960 grams.
He said. “It was horrible for our whole team to see the child turning the corner, leaking and loading. The device really meets the needs of our youngest patients. ”
Francis says that because the Occluder is a preloaded device, it does not require much preparation, և has a softer profile that is easy to install. It has different sizes, so it is suitable for babies of different ages and weights.
In India, about 3.5 million premature babies are born with very low birth weight each year, according to the Central Government’s 2016 Preterm Birth Rate. Another study by the AIIMS-Delhi Department of Pediatrics found that the incidence of PDAs ranged from 15% to 37% in infants weighing less than 1,750 grams.
Overall, PDA accounts for 5-10% of all congenital heart defects, with a prevalence of “symptomatic” PDAs of 0.5 / 1000 live births. This means that the PDA is large; the symptoms are causal, the baby will need treatment to survive.
PDA is one of the most common congenital heart defects in premature babies. It is a life-threatening opening between the two blood vessels coming out of the heart. This wave, found in normal developing fetuses, may be present before birth to allow oxygen-rich blood from the mother to circulate in the fetus. For most babies, the duct or duct is sealed immediately after birth.
In some cases, especially in premature infants, the PDA fails to close automatically, which can make it difficult for babies to breathe normally because of increased blood flow to the lungs. PDA accounts for up to 10% of all congenital heart diseases.